A citation-based method for searching scientific literature

M Decruyenaere, G Evers-Kiebooms, A Boogaerts, J J Cassiman, T Cloostermans, K Demyttenaere, R Dom, J P Fryns, H Van den Berghe. Genet Couns 1995
Times Cited: 69







List of co-cited articles
506 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The psychological consequences of predictive testing for Huntington's disease. Canadian Collaborative Study of Predictive Testing.
S Wiggins, P Whyte, M Huggins, S Adam, J Theilmann, M Bloch, S B Sheps, M T Schechter, M R Hayden. N Engl J Med 1992
345
44

Impact of Event Scale: a measure of subjective stress.
M Horowitz, N Wilner, W Alvarez. Psychosom Med 1979
42



Prediction of psychological functioning one year after the predictive test for Huntington's disease and impact of the test result on reproductive decision making.
M Decruyenaere, G Evers-Kiebooms, A Boogaerts, J J Cassiman, T Cloostermans, K Demyttenaere, R Dom, J P Fryns, H Van den Berghe. J Med Genet 1996
103
39



Predictive testing for Huntington disease: nonparticipants compared with participants in the Dutch program.
I M van der Steenstraten, A Tibben, R A Roos, J J van de Kamp, M F Niermeijer. Am J Hum Genet 1994
103
36

On attitudes and appreciation 6 months after predictive DNA testing for Huntington disease in the Dutch program.
A Tibben, P G Frets, J J van de Kamp, M F Niermeijer, M Vegtervan der Vlis, R A Roos, H G Rooymans, G J van Ommen, F Verhage. Am J Med Genet 1993
95
34



Psychological effects of presymptomatic DNA testing for Huntington's disease in the Dutch program.
A Tibben, H J Duivenvoorden, M F Niermeijer, M Vegter-van der Vlis, R A Roos, F Verhage. Psychosom Med 1994
59
40

Presymptomatic DNA testing for Huntington disease: identifying the need for psychological intervention.
A Tibben, H J Duivenvoorden, M Vegter-van der Vlis, M F Niermeijer, P G Frets, J J van de Kamp, R A Roos, H G Rooijmans, F Verhage. Am J Med Genet 1993
74
33

Presymptomatic DNA-testing for Huntington disease: pretest attitudes and expectations of applicants and their partners in the Dutch program.
A Tibben, P G Frets, J J van de Kamp, M F Niermeijer, M Vegter-van der Vlis, R A Roos, G J van Ommen, H J Duivenvoorden, F Verhage. Am J Med Genet 1993
83
30

Non-participation in predictive testing for Huntington's disease: individual decision-making, personality and avoidant behaviour in the family.
M Decruyenaere, G Evers-Kiebooms, A Boogaerts, T Cloostermans, J J Cassiman, K Demyttenaere, R Dom, J P Fryns, H Van den Berghe. Eur J Hum Genet 1997
52
36


Paradox of a better test for Huntington's disease.
A Maat-Kievit, M Vegter-van der Vlis, M Zoeteweij, M Losekoot, A van Haeringen, R Roos. J Neurol Neurosurg Psychiatry 2000
61
31

Predictive testing for Huntington disease in Canada: adverse effects and unexpected results in those receiving a decreased risk.
M Huggins, M Bloch, S Wiggins, S Adam, O Suchowersky, M Trew, M Klimek, C R Greenberg, M Eleff, L P Thompson. Am J Med Genet 1992
181
26


DNA-testing for Huntington's disease in The Netherlands: a retrospective study on psychosocial effects.
A Tibben, M Vegter-van der Vlis, M I Skraastad, P G Frets, J J van der Kamp, M F Niermeijer, G J van Ommen, R A Roos, H G Rooijmans, D Stronks. Am J Med Genet 1992
74
26


BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.
C Lerman, S Narod, K Schulman, C Hughes, A Gomez-Caminero, G Bonney, K Gold, B Trock, D Main, J Lynch,[...]. JAMA 1996
598
24






Predictive testing for Huntington's disease with use of a linked DNA marker.
G J Meissen, R H Myers, C A Mastromauro, W J Koroshetz, K W Klinger, L A Farrer, P A Watkins, J F Gusella, E D Bird, J B Martin. N Engl J Med 1988
154
23



Self-selection in predictive testing for Huntington's disease.
A M Codori, R Hanson, J Brandt. Am J Med Genet 1994
114
21

The measurement of pessimism: the hopelessness scale.
A T Beck, A Weissman, D Lester, L Trexler. J Consult Clin Psychol 1974
21

Psychological responses to BRCA1 mutation testing: preliminary findings.
R T Croyle, K R Smith, J R Botkin, B Baty, J Nash. Health Psychol 1997
242
21

Attitudes towards predictive testing in Huntington's disease: a recent survey in Belgium.
G Evers-Kiebooms, J J Cassiman, H van den Berghe. J Med Genet 1987
42
35


Psychological functioning before predictive testing for Huntington's disease: the role of the parental disease, risk perception, and subjective proximity of the disease.
M Decruyenaere, G Evers-Kiebooms, A Boogaerts, J J Cassiman, T Cloostermans, K Demyttenaere, R Dom, J P Fryns. J Med Genet 1999
39
38


Age at onset in Huntington's disease: effect of line of inheritance and patient's sex.
R A Roos, M Vegter-van der Vlis, J Hermans, H M Elshove, A C Moll, J J van de Kamp, G W Bruyn. J Med Genet 1991
80
20

Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member.
J D Brook, M E McCurrach, H G Harley, A J Buckler, D Church, H Aburatani, K Hunter, V P Stanton, J P Thirion, T Hudson. Cell 1992
20

Testing for Huntington's disease with support for all parties.
A Tibben, M Vegter-vd Vlis, M F vd Niermeijer, J J Kamp, R A Roos, H G Rooijmans, P G Frets, F Verhage. Lancet 1990
41
34

Interest in genetic testing among first-degree relatives of breast cancer patients.
C Lerman, J Seay, A Balshem, J Audrain. Am J Med Genet 1995
262
18


A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
18

Attitudes about genetic testing for breast-ovarian cancer susceptibility.
C Lerman, M Daly, A Masny, A Balshem. J Clin Oncol 1994
425
18

Myotonic dystrophy. Predictive value of normal results on clinical examination.
H G Brunner, H J Smeets, W Nillesen, B A van Oost, J B van den Biezenbos, E M Joosten, A J Pinckers, B C Hamel, A G Theeuwes, B Wieringa. Brain 1991
27
48

Prediction of myotonic dystrophy clinical severity based on the number of intragenic [CTG]n trinucleotide repeats.
M Gennarelli, G Novelli, F Andreasi Bassi, L Martorell, M Cornet, E Menegazzo, M L Mostacciuolo, J M Martinez, C Angelini, A Pizzuti,[...]. Am J Med Genet 1996
67
19

Five years experience of predictive testing for myotonic dystrophy using linked DNA markers.
W Reardon, J L Floyd, J Myring, L P Lazarou, A L Meredith, P S Harper. Am J Med Genet 1992
22
59

Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.
D Ford, D F Easton, D T Bishop, S A Narod, D E Goldgar. Lancet 1994
17

Predictors of psychological adjustment to genetic testing for Huntington's disease.
A M Codori, P R Slavney, C Young, D L Miglioretti, J Brandt. Health Psychol 1997
64
18



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.